HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Webb, C. F. Articles by Dou, S. Search for Related Content PubMed PubMed Citation Articles by Webb, C. F. Articles by Dou, S.

Expression of Bright at Two Distinct Stages of B Lymphocyte Development¹

Carol F. Webb^2,*,, Elizabeth A. Smith^*, Kay L. Medina^*, Kent L. Buchanan, Glennda Smithson^* and Shenshen Dou^*

^* Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, and Department of Microbiology and Immunology, Oklahoma University Health Sciences Center, Oklahoma City, OK 73104

The B cell regulator of Ig heavy chain transcription (Bright) is a DNA-binding protein that was originally discovered in a mature Ag-specific B cell line after stimulation with IL-5 and Ag. It binds to the intronic heavy chain enhancer and 5' of the V1 S107 family V_H promoter. Several studies suggested that Bright may increase transcription of the heavy chain locus, and expression in cell lines was limited to those representing mature B cells. We have now analyzed normal hemopoietic tissues for the expression of Bright during B lymphocyte differentiation. We expected to find Bright expression in a subset of mature spleen cells, but also observed Bright in a subset of normal B lymphocytic progenitors in both adult bone marrow (BM) and in fetal liver as early as day 12 of gestation. Bright was also expressed in the small percentage of CD4^low cells in the thymus that are newly arrived from the BM and are not yet committed to the T lymphocyte lineage, but was not observed at later stages of T cell differentiation in either the spleen or thymus. Bright mRNA was not detected in the immature B lymphocytes that initially populate the spleen after migration from the BM. In addition, new splice variants of Bright were observed in fetal tissues. Thus, Bright expression is highly regulated in normal murine lymphocytes and occurs both early and late during B cell differentiation. These findings may have important implications for the function of Bright in regulating Ig transcription.

This article has been cited by other articles:

				D. Kim, L. Probst, C. Das, and P. W. Tucker REKLES Is an ARID3-restricted Multifunctional Domain J. Biol. Chem., May 25, 2007; 282(21): 15768 - 15777. [Abstract] [Full Text] [PDF]

				M. Shankar, J. C. Nixon, S. Maier, J. Workman, A. D. Farris, and C. F. Webb Anti-Nuclear Antibody Production and Autoimmunity in Transgenic Mice That Overexpress the Transcription Factor Bright J. Immunol., March 1, 2007; 178(5): 2996 - 3006. [Abstract] [Full Text] [PDF]

				C. M. Johnston, A. L. Wood, D. J. Bolland, and A. E. Corcoran Complete Sequence Assembly and Characterization of the C57BL/6 Mouse Ig Heavy Chain V Region J. Immunol., April 1, 2006; 176(7): 4221 - 4234. [Abstract] [Full Text] [PDF]

				J. Rajaiya, M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb Bruton's Tyrosine Kinase Regulates Immunoglobulin Promoter Activation in Association with the Transcription Factor Bright Mol. Cell. Biol., March 15, 2005; 25(6): 2073 - 2084. [Abstract] [Full Text] [PDF]

				J. C. Nixon, J. Rajaiya, and C. F. Webb Mutations in the DNA-binding Domain of the Transcription Factor Bright Act as Dominant Negative Proteins and Interfere with Immunoglobulin Transactivation J. Biol. Chem., December 10, 2004; 279(50): 52465 - 52472. [Abstract] [Full Text] [PDF]

				K. Ma, K. Araki, S. J.A. Ichwan, T. Suganuma, M. Tamamori-Adachi, and M.-A. Ikeda E2FBP1/DRIL1, an AT-Rich Interaction Domain-Family Transcription Factor, Is Regulated by p53 Mol. Cancer Res., April 1, 2003; 1(6): 438 - 444. [Abstract] [Full Text] [PDF]

				P. Goebel, A. Montalbano, N. Ayers, E. Kompfner, L. Dickinson, C. F. Webb, and A. J. Feeney High Frequency of Matrix Attachment Regions and Cut-Like Protein x/CCAAT-Displacement Protein and B Cell Regulator of IgH Transcription Binding Sites Flanking Ig V Region Genes J. Immunol., September 1, 2002; 169(5): 2477 - 2487. [Abstract] [Full Text] [PDF]

				D. Wilsker, A. Patsialou, P. B. Dallas, and E. Moran ARID Proteins: A Diverse Family of DNA Binding Proteins Implicated in the Control of Cell Growth, Differentiation, and Development Cell Growth Differ., March 1, 2002; 13(3): 95 - 106. [Abstract] [Full Text] [PDF]

				C. F. Webb, Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith The Transcription Factor Bright Associates with Bruton's Tyrosine Kinase, the Defective Protein in Immunodeficiency Disease J. Immunol., December 15, 2000; 165(12): 6956 - 6965. [Abstract] [Full Text] [PDF]

				M. H. Kaplan, R.-T. Zong, R. F. Herrscher, R. H. Scheuermann, and P. W. Tucker Transcriptional Activation by a Matrix Associating Region-binding Protein. CONTEXTUAL REQUIREMENTS FOR THE FUNCTION OF BRIGHT J. Biol. Chem., June 8, 2001; 276(24): 21325 - 21330. [Abstract] [Full Text] [PDF]